Five Prime Therapeutics, Inc.
Records under this name other than the patents Five Prime Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 43 patents it holds.
Back to Five Prime Therapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,765,147 | ANTI-CSFR1 Antibody and Anti PD-1 Antibody Combination Therapy for Cancer Formerly held In force · High confidence | In force | High confidence | |
| US 11,566,076 | Anti-CSF1R Antibody and Anti-PD-1 Antibody Combination Therapy for Selected Cancers Formerly held In force · High confidence | In force | High confidence | |
| US 11,155,615 | Anti-ROR1 antibodies Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,098,103 | CD80 Extracellular Domain Polypeptides and Their Use in Cancer Treatment Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,975,046 | Medical use of interferon-lambda for the treatment of fibrosis Formerly held In force · USPTO record | In force | USPTO record | |
| US 12,195,535 | Antibodies Binding to VISTA at Acidic pH Formerly held In force · High confidence | In force | High confidence | |
| US 11,306,150 | A Method of Identifying a P-Selectin Glycoprotein LIGAND-1 (PSGL-1) Antagonist Formerly held In force · High confidence | In force | High confidence | |
| US 11,603,406 | Antibodies Binding to VISTA at Acidic pH Formerly held In force · High confidence | In force | High confidence | |
| US 11,401,328 | Antibodies Binding to ILT4 Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 12,091,462 | Antibodies Binding to Vista at Acidic pH Formerly held In force · High confidence | In force | High confidence |